v3.26.1

Commitments and Contingencies - Schedule of Milestone Payments that the Group is Required to Pay up to Different Achievements (Details) | Dec. 31, 2025 USD ($)
--- | ---
Drug molecules: up to the conditions and milestones of |
Contingent milestone payments, subtotal | $ 8,720,000
From entering phase 1 to before first commercial sale [Member] |
Drug molecules: up to the conditions and milestones of |
Contingent milestone payments, subtotal | 920,000
First commercial sale [Member] |
Drug molecules: up to the conditions and milestones of |
Contingent milestone payments, subtotal | 800,000
Net sales amount more than certain threshold in a year [Member] |
Drug molecules: up to the conditions and milestones of |
Contingent milestone payments, subtotal | $ 7,000,000

X
- Definition Contingent milestone payments gross total. + References No definition available. + Details
Name: | apm_ContingentMilestonePaymentsSubtotal
Namespace Prefix: | apm_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- References No definition available. + Details
Name: | apm_DrugMoleculesUpToTheConditionsAndMilestonesOfAbstract
Namespace Prefix: | apm_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_OtherCommitmentsAxis=apm_FromEnteringPhase1ToBeforeFirstCommercialSaleMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_OtherCommitmentsAxis=apm_FirstCommercialSaleMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_OtherCommitmentsAxis=apm_NetSalesAmountMoreThanCertainThresholdInAYearMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |